| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.27 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |